Primary Aortic Valve Replacement With Cryopreserved Aortic Allograft. An Echocardiographic Follow-Up Study of 570 Patients
|
|
- Silvia O’Neal’
- 5 years ago
- Views:
Transcription
1 Primary Aortic Valve Replacement With Cryopreserved Aortic Allograft An Echocardiographic Follow-Up Study of 570 Patients Przemysław Palka, MD; Susan Harrocks, BN; Aleksandra Lange, MD; Darryl J. Burstow, MBBS, FRACP; Mark F. O Brien, FRACS Background Despite the many advantages of an aortic allograft valve (AAV) over a prosthetic aortic valve, its durability is suboptimal. The aims of the present study were to document characteristic features of AAV dysfunction and to investigate factors influencing the development of such dysfunction. Methods and Results A group of 570 patients (mean age, years) with a cryopreserved AAV underwent a follow-up echocardiographic study (mean time after surgery, 6.8 years; range, 1.0 to 22.9 years). Significant AAV regurgitation was present in 14.7% of patients, and AAV stenosis was present in 3.2%. The root replacement subgroup had the smallest number of patients with significant AAV regurgitation (5.0%) compared with the subcoronary (23.0%) or the inclusion cylinder technique subgroup (14.7%). After 10 to 15 years after AAV replacement, grade 2 AAV dysfunction was present in 40% of patients in the subcoronary subgroup, but no significant dysfunction was observed in patients in the root replacement subgroup (P 0.001). Smaller host aortic annulus size in both subcoronary (coefficient, 0.145; P 0.013) and root replacement subgroups (coefficient, 0.249; P 0.011) was associated with more frequent AAV dysfunction (grade 2). In addition, significant AAV dysfunction was more frequent when patients were younger (coefficient, 0.020; P 0.015) in the subcoronary subgroup and the donor was older (coefficient, 0.054; P 0.019) in the root replacement subgroup. Conclusions The present study indicates that the root replacement technique is associated with less frequent AAV degeneration. Our findings should help in establishing more strict selection criteria for surgical replacement procedure type and patient/donor factors for AAV replacement and, therefore, could lead to improve AAV longevity. (Circulation. 2002;105:61-66.) Key Words: heart diseases echocardiography surgery The aortic allograft valve (AAV) has been in use for the surgical treatment of aortic valves since the late 1950s. Major advantages of the AAV in early studies 1 5 were related to good hemodynamics of AAV function, without the need for anticoagulation. Relatively recent studies have shown that the AAV should be considered the valve of choice in patients with active endocarditis due to the low risk of recurrent postoperative valve infection However, like other tissue valves, AAV durability is still suboptimal AAV degeneration usually accelerates 10 to 15 years after implantation, making a reoperation a likely scenario for younger patients. 7 The causes of AAV degeneration are under intense investigation, but they seem to be complex and multifactorial. 14 Immunological rejection, mechanical stress, ischemia, and/or chemical insults all may cause AAV degeneration, with the likely trigger mechanism being endothelial activation in response to tissue injury leading to smooth muscle cell proliferation and cell apoptosis. Thus, recipient and donor factors, including methods of AAV sterilization and preservation that may influence the severity of immunological reaction and factors such as implantation technique that can modify the mechanical function of the allograft, may all influence AAV longevity. 15 The aims of this study were (1) to document, using transthoracic echocardiography, the characteristic features of AAV degeneration and (2) to investigate the potential factors influencing the development of specific forms of AAV dysfunction. Methods Subjects From December 1969 to July 1998, 1022 patients (mean age, years; range, 1.2 to 80.8 years; 669 were male) underwent primary AAV replacement at the Department of Surgery, the Prince Charles Hospital and St Andrew s War Memorial Hospital, Brisbane, Australia. Until June 1996, when the current study commenced, 223 Received July 27, 2001; revision received October 15, 2001; accepted October 21, From the Departments of Echocardiography (P.P., A.L., D.J.B.) and Cardiac Surgery (S.H., M.F.O.), the Prince Charles Hospital, Brisbane, Australia. Correspondence to Dr P. Palka, Department of Echocardiography, The Prince Charles Hospital, Rode Road, Brisbane Qld-4032, Australia. ppalka@hotmail.com 2002 American Heart Association, Inc. Circulation is available at 61
2 62 Circulation January 1/8, 2002 TABLE 1. Preoperative Patients and Donor Valve Characteristics patients had died, 126 patients had undergone reoperation, and 7 patients were lost to follow-up. Thus, from the entire group of 1022 patients, 666 AAV patients were eligible for the inclusion into the study. However, 51 patients did not undergo echocardiographic assessment for various reasons, and 37 AAV patients with a follow-up 1-year and 8 patients with fresh ( nonviable ) AAV were excluded from the study. The final study group consisted of 570 patients. In our previous study based on the current cohort of patients, we assessed AAV durability and the associated risk of reoperation in view of AAV structural degeneration. 16 All study patients had cryopreserved (in liquid nitrogen at 196 C) AAVs. 7 Cryopreserved AAVs are considered to have at least 50% leaflet viability (interstitial cells) at the time of valve implantation. 17 All AAVs came from the Queensland homograft valve bank at the Prince Subcoronary (n 278) Root Replacement (n 258) Inclusion Cylinder (n 34) All AAV (n 570) Patients Age, y (range) ( ) ( ) ( ) ( ) Sex, male/female 149/ /61 28/6 374/196 NYHA classification I, n (%) 29 (10) 61 (24) 4 (12) 94 (16) II, n (%) 162 (58) 132 (51) 22 (65) 316 (55) III, n (%) 66 (24) 47 (18) 3 (9) 116 (20) IV, n (%) 21 (8) 18 (7) 5 (15) 44 (8) Aortic annulus size, mm 25 3* Aortic valve disease, n (%) Stenosis 182 (65) 100 (39) 14 (41) 296 (52) Regurgitation 68 (24) 128 (50) 17 (50) 213 (37) Mixed 28 (10) 30 (12) 3 (9) 61 (11) Cause, n (%) Bicuspid 153 (55) 130 (50) 16 (47) 299 (52) Degenerative 33 (12) 8 (3) 0 41 (7) Rheumatic 39 (14) 17 (7) 5 (15) 61 (11) Post endocarditis 7 (3) 4 (2) 2 (6) 13 (2) Active endocarditis 28 (10) 18 (7) 4 (12) 50 (9) Aortic wall disease (eg, Marfan syndrome) 2 ( 1) 62 (24) 5 (15) 69 (12) Prosthetic valve dysfunction 16 (6) 25 (8) 3 (9) 40 (7) Other (eg, trauma, postradiation) 1 ( 1) 3 (1) 0 4 ( 1) LV systolic dysfunction, n (%) 12 (4) 9 (3) 3 (9) 24 (4) Systemic hypertension, n (%) 70 (25) 54 (21) 8 (24) 132 (23) Atrial fibrillation, n (%) 12 (4) 10 (4) 2 (6) 24 (4) Renal dysfunction, n (%) 5 (2) 3 (1) 2 (6) 10 (2) Diabetes, n (%) 13 (5) 3 (1) 2 (6) 18 (3) Respiratory dysfunction, n (%) 6 (2) 6 (2) 1 (3) 13 (2) Neurological disorders, n (%) 7 (3) 11 (4) 0 18 (3) Donor valve Age, y (range) * ( ) ( ) ( ) ( ) Sex, male/female 190/88 203/55 27/7 420/150 Aortic annulus size, mm 23 2* Values are mean SD (range) or n (%). NYHA indicates New York Heart Association; LV, left ventricle. *P 0.01 vs aortic root or inclusion cylinder subgroups; P 0.05 vs subcoronary or inclusion cylinder subgroup; P 0.01 vs inclusion cylinder subgroup. Charles Hospital, where all donor characteristics were kept for permanent record. Sizing of the annulus was performed in a meticulous order to minimize potential measurement-related errors. For the donor, this was done by distending the aorta to a pressure of 80 mm Hg and measuring the ventricular aspect of the actual diameter of the valve annulus with coapted valve leaflets. For the host, measurements were made using standard, commercially available valve size obturators (of the St Jude type). AAV replacement was performed using the subcoronary technique in 278 patients, the aortic root replacement technique in 258 patients, and the inclusion cylinder technique in 34 patients (Table 1). After observing that the subcoronary technique is (1) more difficult to perform in an asymmetric/dilated aortic root and (2) related to immediate trivial/mild AAV regurgitation, the root replacement
3 Palka et al Echocardiographic Follow-Up of AAV 63 TABLE 2. Quantitative Echocardiographic Criteria for AAV Stenosis or Regurgitation Grade Mean Gradient, mm Hg Aortic Valve Area, cm 2 AAV stenosis 1 (Mild) (Moderate) (Severe) Effective Regurgitant Orifice, mm 2 Regurgitation Fraction, % AAV regurgitation 1 (Mild) (Moderate to moderately severe) 4 (Severe) technique was used predominantly in our center to implant AAV (since 1985). 16 All operations were performed with a single, 6-member surgical team, with two-thirds of the operations performed by 2 senior surgeons. Technical differences in the different surgical procedures of AAV replacement were previously described in detail. 18 Study Protocol Transthoracic echocardiographic studies were performed between June 1996 and December 1998 in all 570 patients in the following echocardiographic laboratories in Brisbane and other metropolitan centers: The Prince Charles Hospital, St Andrew s War Memorial Hospital, Wesley Hospital, Princess Alexandra Hospital, Toowoomba Base Hospital, and Queensland X-ray service. Each patient underwent standard echocardiographic study according to the same protocol using commercially available ultrasound scanners. Informed consent was obtained from all subjects before the study. AAV stenosis was divided into 3 grades of severity, and AAV regurgitation was divided into 4 grades using previously validated criteria (Table 2) Statistical Analysis The data are expressed as mean SD for continuous variables and as frequency [number (%)] for dichotomous variables. ANOVA with Scheffe s F adjustment for multiple comparisons was used to assess the differences between AAV patients operated on using different surgical techniques. 2 tests were used when appropriate. Cox regression analysis was performed to assess the relationship between the patient/donor factors (age, sex, aortic annulus size, blood groups), patient clinical information (NYHA classification, type of native aortic valve disease, other underlying disorders) and the severity of AAV dysfunction. P 0.05 was considered significant. Results In all 570 patients, the average time to an echocardiogram after the AAV replacement was years (range, 1.0 to 22.9 years). In the subcoronary group, this time period was longer than in the root replacement or inclusion cylinder group ( versus and years, respectively; P 0.001). In the entire group, 27.9% patients had no signs of AAV dysfunction at the time of an echocardiogram (Figure 1). A total of 309 patients (54.2%) had grade 1 AAV regurgitation or stenosis (44.2% and 10.0%, respectively); 76 patients (13.3%) had grade 2 AAV regurgitation (10.9%) or grade 2 AAV stenosis (2.5%). Only 4.6% had moderately severe or severe AAV dysfunction (regurgitation of grades 3 or 4 or stenosis of grade 3). Grade 3 and 4 AAV regurgitation was present in 3.9% of patients, and grade 3 AAV stenosis existed in 1% patients. As expected, AAV dysfunction occurred more often at a later stage after AAV implantation. However, there were no differences in time between patients with grade 1 regurgitation or grade 3 AAV stenosis and patients with no signs of AAV dysfunction ( and versus years, respectively; P NS). Also, there was no difference between patients with grade 2 to 4 AAV regurgitation and those with grade 2 or 3 AAV stenosis ( versus years; P NS). In the subcoronary subgroup, only 15.5% of patients compared with 42.2% in the root replacement and 20.6% in the inclusion cylinder subgroup had no signs of AAV dysfunction. The root replacement group had the smallest number of patients with grade 2 to 4 AAV regurgitation (5.4%) compared with the subcoronary (23.7%) or the inclusion cylinder technique (14.7%). Grade 2 and 3 AAV stenosis was observed in a similar percentage of patients in all subgroups (4.3% in the subcoronary, 1.9% in the root replacement, and 2.9% in the inclusion cylinder subgroups). Also, hemodynamic indices of AAV function were lower in the subcoronary subgroup compared with the other subgroups (Table 3). After 5 to 10 years after AAV replacement, Figure 1. Plot graph presenting the relation between time period after AAV surgery and the type and severity of AAV dysfunction. Empty circles indicate individual data; filled circles, mean value; and solid lines, standard deviation.
4 64 Circulation January 1/8, 2002 TABLE 3. Conventional M-Mode and 2D Measurements of Study Group of 570 AAV Patients Variable Subcoronary Root Replacement Inclusion Cylinder All AAV AAV Peak gradient, mm Hg 20 13* Mean gradient, mm Hg 11 7* Area, cm LV end-diastolic dimension, cm LV end-systolic dimension, cm LV posterior wall thickness, mm LV septal thickness, mm LV ejection fraction, % LV fractional shortening, % LV end-diastolic volume, ml LV outflow tract diameter, mm Values are mean SD. LV indicates left ventricular. *P 0.01 vs aortic root subgroup; P 0.05 vs inclusion cylinder subgroup; P vs aortic root or inclusion cylinder subgroup; P vs subcoronary or root replacement subgroup; P 0.01 vs subcoronary or root replacement subgroup; P 0.05 vs subcoronary or root replacement subgroup. significant valve dysfunction (grade 2) was present in 21.5% of patients in the subcoronary subgroup (n 38) compared with 11.3% (n 7) in the root replacement subgroup (P 0.001). By 10 to 15 years after AAV replacement, grade 2 AAV dysfunction was present in 40% of patients (n 20) in the subcoronary subgroup, but no significant increase in dysfunction (P 0.001) was observed in patients in the root replacement subgroup (n 12; Figure 2). Cox regression analysis of factors influencing AAV degeneration showed that in the subcoronary subgroup, AAV dysfunction (grade 2) was related to smaller host annulus size and the younger age of the recipient. In the root replacement subgroup, AAV degeneration was related to the older age of the donor, but not recipient, and smaller host annulus size (Table 4). Figure 2. Bar graph showing the relationship between the degree of AAV dysfunction and the type of surgical procedure in 5-year time intervals. Note that in contrast to the subcoronary subgroup (solid line), AAV dysfunction does not accelerate 5 years after surgical valve replacement in the root replacement subgroup (dotted line). Discussion The ideal replacement aortic valve, that is, one with perfect hemodynamics, devoid of early and late morbid events, readily available, and usable in all patients with any type of aortic valve disease, does not yet exist and probably never will. However, throughout the quest for this ideal valve, the AAV has always been appealing because human valve tissue is used to replace a diseased human valve. Over the last 3 decades, continuing research work on the cryopreservation technique of viable AAV has produced an improvement in their durability. 7,12,13,15,24 26 However, the causes and the mechanisms of AAV degeneration are not clearly understood. 14 A recently published analysis of our entire cohort of 1022 AAVs demonstrated clear advantages of the aortic allograft for the treatment of acute endocarditis and for use in patients aged 20 years. 16 However, younger patients ( 20 years) experience only a 47% freedom from reoperation from structural degeneration. The current study shows an echocardiographic pattern of AAV dysfunction up to a period of 22 years. We have described the relation between the types and the severity of AAV dysfunction, including an analysis of TABLE 4. Cox Regression Analysis of Host/Donor Factors Influencing AAV Dysfunction (Grade >2) Variable Coefficient Standard Error Wald Statistic P Subcoronary Subgroup Host age (y) Host aortic annulus size (mm) Root replacement subgroup Donor age (y) Host aortic annulus size (mm)
5 Palka et al Echocardiographic Follow-Up of AAV 65 different types of surgical replacement procedures. We have identified patient/donor-related factors influencing AAV degeneration. The data from the entire cohort of AAV patients operated on in our institution showed that the freedom from reoperation due to structural AAV degeneration was indeed similar after the subcoronary and the root replacement technique. 16 However, the present study indicates that in patients who have aortic root replacement, AAV degeneration is less frequent (apparent) and does not accelerate after 10 years compared with the subcoronary technique. We think that our findings may have an important impact on establishing more strict selection criteria for surgical replacement procedure type and patient/donor factors for AAV replacement. Findings Like published data from others, 12 we have shown that AAV replacement can give a good result for up to 22 years, although normal AAV function on echocardiogram is rare after 15 years. However, there are a number of important issues that differentiate our study from others. At our institution, from mid-1975 on, all aortic valves taken from donor hearts were cryopreserved immediately (within 24 hours) after sterilization with antibiotics. The purpose of the cryopreservation method of AAV storage was to retain the viability of the fibroblasts within the leaflets, with the aim of markedly enhancing subsequent valve durability. 20 In the present study, the whole group received cryopreserved AAVs. Thus, our group of AAVs was more homogenous than those used in other studies, 12 where only 20.6% patients had cryopreserved valves. In our institution, since 1985, most surgeons performed the root replacement technique, but other centers still preferred subcoronary implantation. In this study, both subgroups (subcoronary and root replacement) were represented in a similar percentage; however, the time between surgery and echocardiographic follow-up was shorter in the latter subgroup. To our knowledge, this is also the largest AAV group studied, with the longest follow-up by echocardiography. We have found that only 17.9% of patients had at least moderate AAV dysfunction and, among them, only 3.2% had significant (grade 2) AAV stenosis. This is in agreement with previously published data, which showed that the major mode of AAV failure has been aortic regurgitation. 27 As expected, AAV dysfunction occurred more often at a later stage after AAV replacement. Our results are also in agreement with previously published data that showed that AAV primary degeneration rapidly accelerates 10 years after the operation when using the subcoronary approach. 7,11,28 Although our study suggests that in the root replacement technique AAV dysfunction does not accelerate after this time period, a follow-up of 15 years is required to strengthen our findings. In addition, we have shown that there is a different echocardiographic pattern of AAV degeneration in different types of surgical valve replacement procedures. Significant AAV stenosis was observed in a similarly small percentage in all the subgroups, but the root replacement subgroup had the smallest number of patients with significant AAV regurgitation. We are not sure how to explain these differences. Perhaps they are related to the relatively short time of observation in the root replacement subgroup. However, our previous results and the results of others have also shown the advantage of the root replacement technique over the subcoronary technique. 12,24,29 In cases when the complete aortic root is implanted instead of the aortic valve in the subcoronary position, the risk of valve degeneration seems to be smaller. This is due to a lesser mechanical and immunological insult to the valve itself and to the preservation of the short channel connecting the left ventricle to the aorta, which can interact well with the surrounding structures. 30 In the subcoronary subgroup, AAV dysfunction was more frequent in younger recipients. In contrast, in the root replacement technique, older donors (not recipients) had a negative effect on AAV longevity. Although it is already known that a younger recipient carries a higher risk of AAV degeneration, 12,27,28 we have found that this risk occurs predominantly with the subcoronary technique but not in the root replacement surgical procedure. A recent report 12 showed that an older donor (age 65 years) has an inverse effect on AAV durability. Although in our study the oldest donor was 58 years old, we have confirmed these findings. However, this relationship was predominantly seen in the root replacement rather than the subcoronary subgroup. Previously published data emphasize the importance of accurate measurement of the recipient aortic annulus size, with the aim of more appropriate selection of the type of surgical AAV replacement. 12,27 30 It has been suggested that patients with a dilated aortic annulus should be considered for the root replacement rather than the subcoronary technique of AAV implantation. In the present study, we have shown that in patients who underwent either subcoronary or the root AAV replacement technique, a small recipient aortic annulus size had a negative effect on valve durability. Limitations In this study, all subgroups divided according to the surgical AAV replacement technique were not perfectly matched. Patients who had AAVs inserted using the root replacement technique were younger than those who had the subcoronary or the inclusion cylinder technique. The smallest aortic annulus diameter size was observed in the subcoronary subgroup, and the biggest diameter was present in those patients who had inclusion cylinder technique. Also, the patients who underwent subcoronary AAV replacement compared with the root and/or the inclusion cylinder AAV replacement had a lower incidence of native aortic valve regurgitation and the highest incidence of degenerative native aortic valve disease. Although patients who died or had a reoperation due to structural AAV degeneration were not included in the current study, they were all discussed in detail in our previous report. 16 The present study was a snapshot of AAV function at a relatively small point in time, resulting in variable follow-up periods in studied subgroups. However, we think that our echocardiographic study group was representative of the entire cohort of AAV patients and, thus, our results, which include data from all AAV replacement techniques, are of important clinical value. We did not assess the degree of aortic calcification because echocardiography enables only a subjective assessment of calcification and,
6 66 Circulation January 1/8, 2002 because our studies were performed in different centers, the risk of nonhomogenous classification was high. Whenever possible, AAV area measurements were used to minimize possible factors that influence Doppler velocity measurements. Acknowledgments The authors thank The Institute for Cardiovascular Research (Queensland, Australia) for their help in funding this study. References 1. Murray G. Homologous aortic-valve-segment transplants as surgical treatment for aortic and mitral insufficiency. Angiology. 1956;7: Ross DN. Homograft replacement of the aortic valve. Lancet. 1962;2: Duran CG, Gunning AJ. A method for placing a total homologous aortic valve in the subcoronary position. Lancet. 1962;2: Barratt-Boyes BG, Roche AH, Brandt PW, et al. Aortic homograft valve replacement. A long-term follow-up of an initial series of 101 patients. Circulation. 1969;40: Ross D, Yacoub NH. Homograft replacement of the aortic valve: a critical review. Prog Cardiovasc Dis. 1969;11: Haydock D, Barratt-Boyes B, Macedo T, et al. Aortic valve replacement for active infectious endocarditis in 108 patients: a comparison for freehand allograft valves with mechanical prostheses and bioprostheses. J Thorac Cardiovasc Surg. 1992;103: O Brien MF, McGiffin DC, Stafford EG, et al. Allograft aortic valve replacement: long-term comparative clinical analysis of viable cryopreserved and antibiotic stored 4 C stored valves. J Card Surg. 1991;6: Dearani JA, Orszulak TA, Schaff HV, et al. Results of allograft aortic valve replacement for complex endocarditis. J Thorac Cardiovasc Surg. 1997;113: Donaldson RM, Ross DN. Homograft aortic root replacement for complicated prosthetic valve endocarditis. Circulation. 1984;70(suppl 1): Petrou M, Wong K, Albertucci M, et al. Evaluation of unstented aortic homografts for the treatment of prosthetic aortic valve endocarditis. Circulation. 1994;90:II-198 II Barratt-Boyes BG, Roche AH, Subramanyan R, et al. Long-term follow-up patients with antibiotic sterilized aortic homograft valve inserted freehand in the aortic position. Circulation. 1987;75: Lund O, Chandrasekaran V, Grocott-Mason R, et al. Primary aortic valve replacement with allografts over twenty-five years: valve-related and procedure-related determinants of outcome. J Thorac Cardiovasc Surg. 1999;117: Albertucci M, Wong K, Petrou M, et al. The use of unstented homograft valves for aortic valve reoperations: review of a twenty-three-year experience. J Thorac Cardiovasc Surg. 1994;107: Green MK, Walsh MD, Dare A, et al. Histological and immunohistochemical responses after aortic valve allografts in the rat. Ann Thorac Surg. 1998;66:S216 S Grunkemeier GL, Bodnar E. Comparison of structural valve failure among different models of homograft valves. J Heart Valve Dis. 1994; 3: O Brien MF, Harrocks S, Stafford EG, et al. The homograft aortic valve: a 29-year, 99.3% follow up of 1022 valve replacements. J Heart Valve Dis. 2001;10: Gall K, Smith S, Willmette C, et al. Allograft heart valve viability: a quantitative assessment of the effects of valve processing on fibroblast viability and valve processing variables. Ann Thorac Surg. 1998;65: O Brien MF, McGiffin DC, Stafford EG. Allograft aortic valve implantation: Techniques for all types of aortic valve and root pathology. Ann Thorac Surg. 1989;48: Oh JK, Taliercio CP, Holmes DR Jr, et al. Prediction of the severity of aortic stenosis by Doppler aortic valve determination: prospective Doppler-catheter correlation in 100 patients. J Am Coll Cardiol. 1988;11: Zoghbi WA, Farmer KL, Soto JG, et al. Accurate noninvasive quantification of stenotic aortic valve area by Doppler echocardiography. Circulation. 1986;73: Rokey R, Sterling LL, Zoghbi WA, et al. Determination of regurgitant fraction in isolated mitral and aortic regurgitation by pulsed Doppler two-dimensional echocardiography. J Am Coll Cardiol. 1986;7: Enriquez-Sarano M, Bailey KR, Seward JB, et al. Quantitative Doppler assessment of valvular regurgitation. Circulation. 1993;87: Vandervoort PM, Rivera JM, Mele D, et al. Application of color Doppler flow mapping to calculate effective regurgitant orifice area: an in vitro study with initial clinical observations. Circulation. 1993;88: Prager RL, Fisher CR, Kong B, et al. The aortic homograft: evolution of indications, techniques, and results in 107 patients. Ann Thorac Surg. 1997;64: Dearani JA, Orszulak TA, Daly RC, et al. Comparison of techniques for implantation of aortic valve allografts. Ann Thorac Surg. 1996;62: Grocott-Mason RM, Lund O, Elwidaa H, et al. Long-term results after aortic valve replacement in patients with congestive heart failure. Homografts Vs prosthetic valves. Eur Heart J. 2000;21: Staab ME, Nishimura RA, Dearani JA, et al. Aortic valve homografts in adults: a clinical perspective. Mayo Clin Proc. 1998;73: Yacoub M, Rasmi N, Sundt T, et al. Fourteen-year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg. 1995;110: Cabrol C, Pavie A, Mesnildrey P, et al. Long-term results with total replacement of the ascending aorta and reimplantation of the coronary arteries. J Thorac Cardiovasc Surg. 1986;91: Yacoub MH, Kilner PJ, Birks EJ, et al. The aortic outflow and root: a tale of dynamism and crosstalk. Ann Thorac Surg. 1999;68:S37 S43.
Clinical material and methods. Copyright by ICR Publishers 2003
Fourteen Years Experience with the CarboMedics Valve in Young Adults with Aortic Valve Disease Jan Aagaard 1, Jens Tingleff 2, Per V. Andersen 1, Christel N. Hansen 2 1 Department of Cardio-Thoracic and
More informationExpanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?
Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,
More informationOutcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease
Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve
More informationAortic Root Replacement Using an Allograft for Active Infective Endocarditis With Periannular Abscess: Single Center Experience
J Cardiol 2004 Jun; 436: 267 271 : Aortic Root Replacement Using an Allograft for Active Infective Endocarditis With Periannular Abscess: Single Center Experience Kazuhito Shunei Shinichi Noboru Sakiko
More informationThe Ross Procedure: Outcomes at 20 Years
The Ross Procedure: Outcomes at 20 Years Tirone David Carolyn David Anna Woo Cedric Manlhiot University of Toronto Conflict of Interest None The Ross Procedure 1990 to 2004 212 patients: 66% 34% Mean age:
More informationReoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment
Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment W.R.E. Jamieson, MD; L.H. Burr, MD; R.T. Miyagishima, MD; M.T. Janusz, MD; G.J. Fradet, MD; S.V. Lichtenstein, MD; H. Ling, MD Background
More informationTSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD
TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)
More informationLong-term results (22 years) of the Ross Operation a single institutional experience
Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department
More informationManagement of Difficult Aortic Root, Old and New solutions
Management of Difficult Aortic Root, Old and New solutions Hani K. Najm MD, Msc, FRCSC,, FACC, FESC Chairman, Pediatric and Congenital Heart Surgery Cleveland Clinic Conflict of Interest None Difficult
More informationAortic stenosis (AS) is common with the aging population.
New Insights Into the Progression of Aortic Stenosis Implications for Secondary Prevention Sanjeev Palta, MD; Anita M. Pai, MD; Kanwaljit S. Gill, MD; Ramdas G. Pai, MD Background The risk factors affecting
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationExperience with 500 Stentless Aortic Valve Replacements
Experience with 500 Stentless Aortic Valve Replacements Dimitrios C. Iliopoulos, MD Cardiac Surgeon Ass. Professor of Surgery University of Athens, School of Medicine I declare no conflict of interest
More informationWhich Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?
Ann Thorac Cardiovasc Surg 2013; 19: 428 434 Online January 31, 2013 doi: 10.5761/atcs.oa.12.01929 Original Article Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should
More informationProf. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM
The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?
More informationPART II ECHOCARDIOGRAPHY LABORATORY OPERATIONS ADULT TRANSTHORACIC ECHOCARDIOGRAPHY TESTING
PART II ECHOCARDIOGRAPHY LABORATORY OPERATIONS ADULT TRANSTHORACIC ECHOCARDIOGRAPHY TESTING STANDARD - Primary Instrumentation 1.1 Cardiac Ultrasound Systems SECTION 1 Instrumentation Ultrasound instruments
More informationWhat is the Role of Surgical Repair in 2012
What is the Role of Surgical Repair in 2012 The Long-Term Results of Surgery Raphael Rosenhek Department of Cardiology Medical University of Vienna European Society of Cardiology 2012 Munich, August 27th
More informationAdult Echocardiography Examination Content Outline
Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,
More informationThe Role Of Decellularized Valve Prostheses In The Young Patient
The Role Of Decellularized Valve Prostheses In The Young Patient Francisco Diniz Affonso da Costa Human Tissue Bank PUCPR - Brazil Disclosures Ownership and patent license of the SDS decellularization
More informationHani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz
Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for
More informationECHOCARDIOGRAPHY DATA REPORT FORM
Patient ID Patient Study ID AVM - - Date of form completion / / 20 Initials of person completing the form mm dd yyyy Study period Preoperative Postoperative Operative 6-month f/u 1-year f/u 2-year f/u
More informationAutograft or Allograft Aortic Root Replacement in Children and Young Adults With Aortic Valve Disease: A Single-Center Comparison
Autograft or Allograft Aortic Root Replacement in Children and Young Adults With Aortic Valve Disease: A Single-Center Comparison Mark Ruzmetov, MD, PhD, Dale M. Geiss, MD, Jitendra J. Shah, MD, and Randall
More informationPROSTHETIC VALVE BOARD REVIEW
PROSTHETIC VALVE BOARD REVIEW The correct answer D This two chamber view shows a porcine mitral prosthesis with the typical appearance of the struts although the leaflets are not well seen. The valve
More informationThe need for right ventricular outflow tract reconstruction
Polytetrafluoroethylene Bicuspid Pulmonary Valve Implantation James A. Quintessenza, MD The need for right ventricular outflow tract reconstruction and pulmonary valve replacement is increasing for many
More informationEchocardiographic variables associated with mitral regurgitation after aortic valve replacement for aortic valve stenosis
The Egyptian Heart Journal (2013) 65, 135 139 Egyptian Society of Cardiology The Egyptian Heart Journal www.elsevier.com/locate/ehj www.sciencedirect.com ORIGINAL ARTICLE Echocardiographic variables associated
More informationJournal of the American College of Cardiology Vol. 44, No. 9, by the American College of Cardiology Foundation ISSN /04/$30.
Journal of the American College of Cardiology Vol. 44, 9, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.04.062 Relation
More informationEffect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival
Effect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival Sukumaran K. Nair, FRCS (C Th), Gauraang Bhatnagar, MBBS, Oswaldo Valencia, MD, and Venkatachalam Chandrasekaran,
More informationDoppler echocardiography is currently the
Doppler Echocardiography of 119 Normal-functioning St Jude Medical Mitral Valve Prostheses: A Comprehensive Assessment Including Time-velocity Integral Ratio and Prosthesis Performance Index* Joseph F.
More informationDegenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention
Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention John N. Hamaty D.O. FACC, FACOI November 17 th 2017 I have no financial disclosures Primary Mitral
More informationDecellularization of Aortic Homografts: South American and European Current Experience
Department of Cardiac Surgery Instituto de Neurologia e Cardiologia de Curitiba (INC-Cardio) Decellularization of Aortic Homografts: South American and European Current Experience Francisco Diniz Affonso
More informationReconstruction of the intervalvular fibrous body during aortic and
Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body: An analysis of clinical outcomes Nilto C. De Oliveira, MD Tirone E. David, MD Susan Armstrong, MSc Joan Ivanov,
More informationCardiac Surgery A Resource of Experimental Design
Cardiac Surgery A Resource of Experimental Design Complete Transposition: a. Atrial switch the chronically systemic right ventricle b. Arterial switch the suddenly systemic left ventricle Fontan operation
More informationHemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics
Hemodynamic Assessment Matt M. Umland, RDCS, FASE Aurora Medical Group Milwaukee, WI Assessment of Systolic Function Doppler Hemodynamics Stroke Volume Cardiac Output Cardiac Index Tei Index/Index of myocardial
More information42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim
42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim Current Guideline for AR s/p TOF Surgery is reasonable in adults with prior repair of
More information16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900
CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical
More informationAutologous Pulmonary Valve Replacement of the Diseased Aortic Valve
Autologous Pulmonary Valve Replacement of the Diseased Aortic Valve By L. GONZALEZ-LAvIN, M.D., M. GEENS. M.D., J. SOMERVILLE, M.D., M.R.C.P., ANm D. N. Ross, M.B., CH.B., F.R.C.S. SUMMARY Living tissue
More informationaortic regurgitation, vena contracta area, vena contracta width, live three-dimensional echocardiography
RESEARCH FROM THE UNIVERSITY OF ALABAMA AT BIRMINGHAM Assessment of Aortic Regurgitation by Live Three-Dimensional Transthoracic Echocardiographic Measurements of Vena Contracta Area: Usefulness and Validation
More informationPercutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat
Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,
More informationIn , three studies described patients
Heart 2001;85:337 341 VALVE DISEASE Should patients with asymptomatic mild or moderate aortic stenosis undergoing coronary artery bypass surgery also have valve replacement for their aortic stenosis? Shahbudin
More informationDevelopment of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations
Imaging and Diagnostic Testing Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations Jae-Jin Kwak, MD, a Yong-Jin
More informationTAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con
TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con Dimitrios C. Angouras, MD, FETCS Associate Professor of Cardiac Surgery National and Kapodistrian University of Athens,
More informationRoss introduced the replacement of a diseased aortic. The Ross Operation: An Evaluation of a Single Institution s Experience
The Ross Operation: An Evaluation of a Single Institution s Experience Fabrizio Settepani, MD Abdullah Kaya, MD, Wim J. Morshuis, MD, PhD, Marc A. Schepens, MD, PhD, Robin H. Heijmen, MD, PhD, and Karl
More informationAortic valve replacement with the aortic homograft
Aortic Homograft: A Suitable Substitute for Aortic Valve Replacement Sachin Talwar, MCh, Raghunath Mohapatra, MS, Anita Saxena, DM, Rajvir Singh, MS, PhD, and Arkalgud Sampath Kumar, MCh Cardiothoracic
More informationAortic Valve Practice Guidelines: What Has Changed and What You Need to Know
Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know James F. Burke, MD Program Director Cardiovascular Disease Fellowship Lankenau Medical Center Disclosure Dr. Burke has no conflicts
More informationRotation: Echocardiography: Transthoracic Echocardiography (TTE)
Rotation: Echocardiography: Transthoracic Echocardiography (TTE) Rotation Format and Responsibilities: Fellows rotate in the echocardiography laboratory in each clinical year. Rotations during the first
More informationLeft atrial function. Aliakbar Arvandi MD
In the clinic Left atrial function Abstract The left atrium (LA) is a left posterior cardiac chamber which is located adjacent to the esophagus. It is separated from the right atrium by the inter-atrial
More informationUncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency
Uncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency Rahul R. Jhaveri, MD, Muhamed Saric, MD, PhD, FASE, and Itzhak Kronzon, MD, FASE, New York, New York Background: Two-dimensional
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationHOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY?
HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY? John D. Carroll, MD Professor, Director of Interventional Cardiology and Co-Medical Director of the Cardiac and Vascular Center, University of Colorado
More informationICE: Echo Core Lab-CRF
APPENDIX 1 ICE: Echo Core Lab-CRF Study #: - Pt Initials: 1. Date of study: / / D D M M M Y Y Y Y 2. Type of Study: TTE TEE 3. Quality of Study: Poor Moderate Excellent Ejection Fraction 4. Ejection Fraction
More informationA new era in cardiac valve surgery has begun...
THE CENTER FOR VALVE SURGERY A new era in cardiac valve surgery has begun... Good Help to Those in Need Rawn Salenger, MD, FACS, Director, The Center for Valve Surgery Edward F. Lundy, MD, PhD, Chief of
More informationΧειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας
Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Dr Χρήστος ΑΛΕΞΙΟΥ MD, PhD, FRCS(Glasgow), FRCS(CTh), CCST(UK) Consultant Cardiothoracic Surgeon Normal Mitral Valve Function Mitral Regurgitation
More informationchap ter 01 General introduction
chap ter 01 General introduction General introduction General introduction The aorta is not simply a tube or conduit, but a highly complex part of the vascular tree, originating from the left ventricular
More informationSurgery for Valvular Heart Disease. Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse
Surgery for Valvular Heart Disease Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse Dania Mohty, MD; Thomas A. Orszulak, MD; Hartzell V. Schaff, MD; Jean-Francois
More informationPresenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose
Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material
More informationQuality Outcomes Mitral Valve Repair
Quality Outcomes Mitral Valve Repair Moving Beyond Reoperation Rakesh M. Suri, D.Phil. Professor of Surgery 2015 MFMER 3431548-1 Disclosure Mayo Clinic Division of Cardiovascular Surgery Research funding
More informationMedium-Term Determinants of Left Ventricular Mass Index After Stentless Aortic Valve Replacement
Medium-Term Determinants of Left Ventricular Mass Index After Stentless Aortic Valve Replacement Xu Y. Jin, MD, PhD, Ravi Pillai, FRCS, and Stephen Westaby, FRCS Department of Cardiac Surgery, Oxford Heart
More informationRegression of Hypertrophy After Carpentier-Edwards Pericardial Aortic Valve Replacement
Regression of Hypertrophy After Carpentier-Edwards Pericardial Aortic Valve Replacement Steven S. Khan, MD, Robert J. Siegel, MD, Michele A. DeRobertis, RN, Carlos E. Blanche, MD, Robert M. Kass, MD, Wen
More information: mm 86 mm EF mm
37 Vol. 35, pp. 37 42, 2007 2 3 : 9 6 22 68 40 2003 4 Ejection fraction: EF44 IV 70 mm 86 mm EF46 6 24 mm 4 mm EF 80 60 mm 70 mm Aortic Regurgitation: AR 2 3 AR Aortic Valve Replacement: AVR AR 38 : 68
More informationCLINICAL COMMUNIQUE 16 YEAR RESULTS
CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced
More informationSotirios N. Prapas, M.D., Ph.D, F.E.C.T.S.
CORONARY ARTERY REVASCULARIZATION WITH MILD AORTIC STENOSIS: STRATEGIES OF TREATMENT 9 th ANNUAL MEETING OF THE EAB SOCIETY, Pravets, Bulgaria, 2012 Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S. Director
More informationSeverity of AS Degree of AV calcification (? Bicuspid AV), annulus size, & aortic root
The role of Cardiac Imaging modalities in evaluation & selection of patients for Trans-catheter Aortic Valve Implantation Dr.Saeed AL Ahmari Consultant Cardiologist Prince Sultan Cardaic Center, Riyadh
More informationMitral Valve Disease, When to Intervene
Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages
More informationPULMONARY HOMOGRAFT: SHOULD IT BE USED IN THE AORTIC POSITION?
PULMONARY HOMOGRAFT: SHOULD IT BE USED IN THE AORTIC POSITION? Shiv Kumar Choudhary, MCh Anita Saxena, DM Bharat Dubey, MS A. Sampath Kumar, MCh Objective: Retrospective analysis was performed to determine
More informationRestoration of Sinus Rhythm by the Maze Procedure Halts Progression of Tricuspid Regurgitation After Mitral Surgery
Restoration of Sinus Rhythm by the Maze Procedure Halts Progression of Tricuspid Regurgitation After Mitral Surgery John M. Stulak, MD,* Hartzell V. Schaff, MD, Joseph A. Dearani, MD, Thomas A. Orszulak,
More informationAlthough mitral valve replacement (MVR) is no longer the surgical
Surgery for Acquired Cardiovascular Disease Ruel et al Late incidence and predictors of persistent or recurrent heart failure in patients with mitral prosthetic valves Marc Ruel, MD, MPH a,b Fraser D.
More informationChapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine
Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine Mitral regurgitation, regurgitant flow between the
More informationThe production of murmurs is due to 3 main factors:
Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or
More information25 different brand names >44 different models Sizes mm
Types of Prosthetic Valves BIOLOGIC STENTED Porcine xenograft Pericardial xenograft STENTLESS Porcine xenograft Pericardial xenograft Homograft (allograft) Autograft PERCUTANEOUS MECHANICAL Bileaflet Single
More informationTricuspid and Pulmonic Valve Disease
Chapter 31 Tricuspid and Pulmonic Valve Disease David A. Tate Acquired disease of the right-sided cardiac valves is much less common than disease of the leftsided counterparts, possibly because of the
More informationSemilunar Valve Switch Procedure: Autotransplantation of the Native Aortic Valve to the Pulmonary Position in the Ross Procedure
Semilunar Valve Switch Procedure: Autotransplantation of the Native Aortic Valve to the Pulmonary Position in the Ross Procedure Patrick T. Roughneen, FRCS, Serafin Y. DeLeon, MD, Benjamin W. Eidem, MD,
More informationIncidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation
Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation Ömer Aktug 1, MD; Guido Dohmen 2, MD; Kathrin Brehmer 1, MD; Verena Deserno 1 ; Ralf Herpertz 1 ; Rüdiger
More informationAortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines -
Reconstruction of the Aortic Valve and Root - A Practical Approach - Aortic Regurgitation and Aortic Aneurysm Wednesday 14 th September - 9.45 Practice must always be founded on sound theory. Leonardo
More information7. Echocardiography Appropriate Use Criteria (by Indication)
Criteria for Echocardiography 1133 7. Echocardiography Criteria (by ) Table 1. TTE for General Evaluation of Cardiac Structure and Function Suspected Cardiac Etiology General With TTE 1. Symptoms or conditions
More informationCase # 1. Page: 8. DUKE: Adams
Case # 1 Page: 8 1. The cardiac output in this patient is reduced because of: O a) tamponade physiology O b) restrictive physiology O c) coronary artery disease O d) left bundle branch block Page: 8 1.
More informationUnderstanding the guidelines for Interventions in MR. Ali AlMasood
Understanding the guidelines for Interventions in MR Ali AlMasood Mitral regurgitation The most diverse from all acquired valve diseases About 50% of patients with an LVEF 35 percent had moderate to severe
More informationECHOCARDIOGRAPHY. Patient Care. Goals and Objectives PF EF MF LF Aspirational
Patient Care Be able to: Perform and interpret basic TTE and X cardiac Doppler examinations Perform and interpret a comprehensive X TTE and cardiac Doppler examination Perform and interpret a comprehensive
More informationEffect of Heart Rate on Tissue Doppler Measures of E/E
Cardiology Department of Bangkok Metropolitan Administration Medical College and Vajira Hospital, Bangkok, Thailand Abstract Background: Our aim was to study the independent effect of heart rate (HR) on
More informationOutline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II
SURGICAL RISK IN VALVULAR HEART DISEASE: WHAT 2D AND 3D ECHO CAN TELL YOU AND WHAT THEY CAN'T Ernesto E Salcedo, MD Professor of Medicine University of Colorado School of Medicine Director of Echocardiography
More informationBogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010
Bogdan A. Popescu University of Medicine and Pharmacy Bucharest, Romania EAE Course, Bucharest, April 2010 This is how it started Mitral stenosis at a glance 2D echo narrow diastolic opening of MV leaflets
More informationEchocardiographic and Doppler Assessment of Cardiac Functions in Patients of Non-Insulin Dependent Diabetes Mellitus
ORIGINAL ARTICLE JIACM 2002; 3(2): 164-8 Echocardiographic and Doppler Assessment of Cardiac Functions in Patients of Non-Insulin Dependent Diabetes Mellitus Rajesh Rajput*, Jagdish**, SB Siwach***, A
More informationTAVR: Echo Measurements Pre, Post And Intra Procedure
2017 ASE Florida, Orlando, FL October 10, 2017 8:00 8:25 AM 25 min TAVR: Echo Measurements Pre, Post And Intra Procedure Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate
More informationEight-Year Results of Aortic Root Replacement With the Freestyle Stentless Porcine Aortic Root Bioprosthesis
Eight-Year Results of Aortic Root Replacement With the Freestyle Stentless Porcine Aortic Root Bioprosthesis Neal D. Kon, MD,* Robert D. Riley, MD, Sandy M. Adair, RN, Dalane W. Kitzman, MD, and A. Robert
More informationSince first successfully performed by Jatene et al, the
Long-Term Predictors of Aortic Root Dilation and Aortic Regurgitation After Arterial Switch Operation Marcy L. Schwartz, MD; Kimberlee Gauvreau, ScD; Pedro del Nido, MD; John E. Mayer, MD; Steven D. Colan,
More informationTitle of image and video article Sub-Acute Leaflet Thrombosis: A Reversible Cause of Aortic Stenosis
Page 1 of 5 Title of image and video article Sub-Acute Leaflet Thrombosis: A Reversible Cause of Aortic Stenosis Authors Athina Chasapi, Adam Hobbs, Theodore Velissaris & Benoy N Shah. Wessex Cardiac &
More informationHani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.
Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Decision process for Management of any valve Timing Feasibility
More informationEchocardiography as a diagnostic and management tool in medical emergencies
Echocardiography as a diagnostic and management tool in medical emergencies Frank van der Heusen MD Department of Anesthesia and perioperative Care UCSF Medical Center Objective of this presentation Indications
More informationProsthetic valve dysfunction: stenosis or regurgitation
Prosthetic valve dysfunction: stenosis or regurgitation Jean G. Dumesnil MD, FRCP(C), FACC, FASE(Hon) Quebec Heart and Lung Institute, Québec, Québec No disclosures Possible Causes of High Gradients in
More informationThe production of murmurs is due to 3 main factors:
Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or
More informationJournal of the American College of Cardiology Vol. 42, No. 3, by the American College of Cardiology Foundation ISSN /03/$30.
Journal of the American College of Cardiology Vol. 42, No. 3, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00649-1
More informationCase. 15-year-old boy with bicuspid AV Severe AR with moderate AS. Ross vs. AVR (or AVP)
Case 15-year-old boy with bicuspid AV Severe AR with moderate AS Ross vs. AVR (or AVP) AMC case 14-year-old boy with bicuspid AV Severe AS with mild AR Body size Bwt: 55 kg, Ht: 154 cm, BSA: 1.53 m 2 Echocardiography
More informationPediatric Echocardiography Examination Content Outline
Pediatric Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 Anatomy and Physiology Normal Anatomy and Physiology 10% 2 Abnormal Pathology and Pathophysiology
More informationAortic Stenosis and Perioperative Risk With Non-cardiac Surgery
Aortic Stenosis and Perioperative Risk With Non-cardiac Surgery Aortic stenosis (AS) is characterized as a high-risk index for cardiac complications during non-cardiac surgery. A critical analysis of old
More informationSONOGRAPHER & NURSE LED VALVE CLINICS
SONOGRAPHER & NURSE LED VALVE CLINICS Frequency of visits and alerts AORTIC STENOSIS V max > 4.0 m/s or EOA < 1.0 cm 2 V max 3.5 4.0 m/s + Ca+ V max 3.0 4.0 m/s or EOA 1.0-1.5 cm 2 V max 2.5 3.0 m/s every
More informationValve Disease Board Review Questions
Valve Disease Board Review Questions Dennis A. Tighe, MD, FASE University of Massachusetts Medical School Worcester, MA Case 1 History A 61 year-old man Presents to hospital with worsening shortness of
More informationReoperations after primary aortic valve replacement
Third-Time Aortic Valve Replacement: Patient s and Operative Outcome Kasra Shaikhrezai, MD, MRCS, Giordano Tasca, MD, FETCS, Mohamed Amrani, PhD, FETCS, Gilles Dreyfus, MD, FETCS, and George Asimakopoulos,
More informationEvaluation of St. Jude Medical Valve s Long-term Function by Doppler Echocardiography
Evaluation of St. Jude Medical Valve s Long-term Function by Doppler Echocardiography Akira Sezai, MD, Motomi Shiono, MD, Kenji Akiyama, MD, Yukihiko Orime, MD, Hiroaki Hata, MD, Shinya Yagi, MD, Tomonori
More informationObjectives. Diastology: What the Radiologist Needs to Know. LV Diastolic Function: Introduction. LV Diastolic Function: Introduction
Objectives Diastology: What the Radiologist Needs to Know. Jacobo Kirsch, MD Cardiopulmonary Imaging, Section Head Division of Radiology Cleveland Clinic Florida Weston, FL To review the physiology and
More informationClinical material and methods. Fukui Cardiovascular Center, Fukui, Japan
Mitral Valve Regurgitation after Atrial Septal Defect Repair in Adults Shohei Yoshida, Satoshi Numata, Yasushi Tsutsumi, Osamu Monta, Sachiko Yamazaki, Hiroyuki Seo, Takaaki Samura, Hirokazu Ohashi Fukui
More informationA Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision
A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction
More information